AIM
IMGN

Alambic Investment Management’s Immunogen Inc IMGN Stock Holding History

Alambic Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,081
Closed -$264K – 473
2018
Q1 		$264K Buy
25,081
+2,169
+9% +$21.4K 0.04% 385
2017
Q4 		$147K Sell
22,912
-180,685
-89% -$1.11M 0.02% 427
2017
Q3 		$1.56M Buy
203,597
+165,582
+436% +$1.1M 0.17% 195
2017
Q2 		$270K Buy
+38,015
New +$174K 0.03% 472
2016
Q4 		– Sell
-28,700
Closed -$77K – 603
2016
Q3 		$77K Sell
28,700
-49,300
-63% -$143K 0.02% 485
2016
Q2 		$240K Buy
+78,000
New +$489K 0.06% 419

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alambic Investment Management's IMGN Position: Q2 2018 in Review

Alambic Investment Management sold out of Immunogen Inc (IMGN) in Q2 2018, closing a stake of 25,081 shares — an estimated $264K sold.

Alambic Investment Management first reported a position in IMGN in Q2 2016 and held it in 6 quarters. The position peaked at $1.56M in Q3 2017. 198 funds tracked by Wall St. Rank hold IMGN as of Q2 2018.

  • Alambic Investment Management reported no remaining Immunogen Inc position as of Q2 2018 after selling out during the quarter.
  • Alambic Investment Management sold 25,081 Immunogen Inc shares in Q2 2018, an estimated $264K.
  • Alambic Investment Management first reported a position in Immunogen Inc in Q2 2016 and held it in 6 quarters.
  • Alambic Investment Management's Immunogen Inc position peaked at $1.56M in Q3 2017.
  • 198 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2018.

Based on Alambic Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.